NTLA logo

Intellia Therapeutics, Inc. (NTLA) Cash From Investing

Annual CFI:

$125.57M+$156.91M(+500.57%)
December 31, 2024

Summary

  • As of today, NTLA annual cash from investing is $125.57 million, with the most recent change of +$156.91 million (+500.57%) on December 31, 2024.
  • During the last 3 years, NTLA annual cash from investing has risen by +$676.35 million (+122.80%).
  • NTLA annual cash from investing is now -21.67% below its all-time high of $160.31 million, reached on December 31, 2022.

Performance

NTLA Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNTLAcash flow metrics

Quarterly CFI:

-$741.00K-$107.65M(-100.69%)
September 30, 2025

Summary

  • As of today, NTLA quarterly cash from investing is -$741.00 thousand, with the most recent change of -$107.65 million (-100.69%) on September 30, 2025.
  • Over the past year, NTLA quarterly cash from investing has increased by +$6.97 million (+90.39%).
  • NTLA quarterly cash from investing is now -100.49% below its all-time high of $151.56 million, reached on December 31, 2024.

Performance

NTLA Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNTLAcash flow metrics

TTM CFI:

$352.06M+$6.97M(+2.02%)
September 30, 2025

Summary

  • As of today, NTLA TTM cash from investing is $352.06 million, with the most recent change of +$6.97 million (+2.02%) on September 30, 2025.
  • Over the past year, NTLA TTM cash from investing has increased by +$332.12 million (+1665.52%).
  • NTLA TTM cash from investing is now at all-time high.

Performance

NTLA TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNTLAcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

NTLA Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+500.6%+90.4%+1665.5%
3Y3 Years+122.8%-101.6%+1023.1%
5Y5 Years+398.8%+99.5%+1347.9%

NTLA Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-21.7%+122.8%-100.5%+99.4%at high+352.8%
5Y5-Year-21.7%+122.8%-100.5%+99.8%at high+158.4%
All-TimeAll-Time-21.7%+122.8%-100.5%+99.8%at high+158.4%

NTLA Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2025
-
-$741.00K(-100.7%)
$352.06M(+2.0%)
Jun 2025
-
$106.91M(+13.3%)
$345.09M(+61.3%)
Mar 2025
-
$94.33M(-37.8%)
$213.99M(+70.4%)
Dec 2024
$125.57M(+500.6%)
$151.56M(+2066.1%)
$125.57M(+529.7%)
Sep 2024
-
-$7.71M(+68.1%)
$19.94M(-81.4%)
Jun 2024
-
-$24.19M(-509.9%)
$107.15M(+10.7%)
Mar 2024
-
$5.90M(-87.2%)
$96.80M(+408.8%)
Dec 2023
-$31.35M(-119.6%)
$45.94M(-42.2%)
-$31.35M(+70.8%)
Sep 2023
-
$79.50M(+330.2%)
-$107.44M(+22.9%)
Jun 2023
-
-$34.54M(+71.7%)
-$139.29M(-1380.0%)
Mar 2023
-
-$122.25M(-305.4%)
-$9.41M(-105.9%)
Dec 2022
$160.31M(+129.1%)
-$30.15M(-163.3%)
$160.31M(+411.4%)
Sep 2022
-
$47.64M(-50.0%)
$31.35M(+107.5%)
Jun 2022
-
$95.34M(+100.8%)
-$415.68M(+13.0%)
Mar 2022
-
$47.47M(+129.8%)
-$477.76M(+13.3%)
Dec 2021
-$550.78M(-156.8%)
-$159.12M(+60.2%)
-$550.78M(+8.6%)
Sep 2021
-
-$399.38M(-1300.8%)
-$602.58M(-68.7%)
Jun 2021
-
$33.26M(+230.2%)
-$357.18M(-20.1%)
Mar 2021
-
-$25.54M(+87.9%)
-$297.48M(-38.7%)
Dec 2020
-$214.49M
-$210.92M(-37.0%)
-$214.49M(-982.1%)
Sep 2020
-
-$153.98M(-265.6%)
$24.32M(-83.4%)
Jun 2020
-
$92.96M(+61.8%)
$146.64M(+90.6%)
DateAnnualQuarterlyTTM
Mar 2020
-
$57.45M(+106.0%)
$76.93M(+205.6%)
Dec 2019
$25.18M(+109.7%)
$27.88M(+188.1%)
$25.18M(+109.7%)
Sep 2019
-
-$31.65M(-236.1%)
-$258.72M(-12.9%)
Jun 2019
-
$23.25M(+308.2%)
-$229.09M(+9.5%)
Mar 2019
-
$5.70M(+102.2%)
-$253.24M(+2.9%)
Dec 2018
-$260.78M(-2484.3%)
-$256.02M(>-9900.0%)
-$260.78M(-3540.7%)
Sep 2018
-
-$2.02M(-124.0%)
-$7.16M(+3.3%)
Jun 2018
-
-$900.00K(+51.4%)
-$7.41M(+4.8%)
Mar 2018
-
-$1.85M(+22.8%)
-$7.78M(+22.9%)
Dec 2017
-$10.09M(-63.7%)
-$2.40M(-6.1%)
-$10.09M(+9.1%)
Sep 2017
-
-$2.26M(-77.7%)
-$11.10M(-17.5%)
Jun 2017
-
-$1.27M(+69.4%)
-$9.44M(-1.3%)
Mar 2017
-
-$4.16M(-22.2%)
-$9.32M(-51.2%)
Dec 2016
-$6.17M(-141.4%)
-$3.40M(-462.8%)
-$6.17M(-70.8%)
Sep 2016
-
-$605.00K(+47.3%)
-$3.61M(-0.1%)
Jun 2016
-
-$1.15M(-13.8%)
-$3.61M(-18.4%)
Mar 2016
-
-$1.01M(-18.7%)
-$3.05M(-19.3%)
Dec 2015
-$2.55M(-344.2%)
-$849.00K(-41.0%)
-$2.55M(-49.8%)
Sep 2015
-
-$602.00K(-2.6%)
-$1.71M(-54.6%)
Jun 2015
-
-$587.00K(-13.8%)
-$1.10M(-113.8%)
Mar 2015
-
-$516.00K
-$516.00K
Dec 2014
-$575.00K
-
-

FAQ

  • What is Intellia Therapeutics, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Intellia Therapeutics, Inc.?
  • What is Intellia Therapeutics, Inc. annual cash from investing year-on-year change?
  • What is Intellia Therapeutics, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Intellia Therapeutics, Inc.?
  • What is Intellia Therapeutics, Inc. quarterly cash from investing year-on-year change?
  • What is Intellia Therapeutics, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Intellia Therapeutics, Inc.?
  • What is Intellia Therapeutics, Inc. TTM cash from investing year-on-year change?

What is Intellia Therapeutics, Inc. annual cash from investing?

The current annual cash from investing of NTLA is $125.57M

What is the all-time high annual cash from investing for Intellia Therapeutics, Inc.?

Intellia Therapeutics, Inc. all-time high annual cash from investing is $160.31M

What is Intellia Therapeutics, Inc. annual cash from investing year-on-year change?

Over the past year, NTLA annual cash from investing has changed by +$156.91M (+500.57%)

What is Intellia Therapeutics, Inc. quarterly cash from investing?

The current quarterly cash from investing of NTLA is -$741.00K

What is the all-time high quarterly cash from investing for Intellia Therapeutics, Inc.?

Intellia Therapeutics, Inc. all-time high quarterly cash from investing is $151.56M

What is Intellia Therapeutics, Inc. quarterly cash from investing year-on-year change?

Over the past year, NTLA quarterly cash from investing has changed by +$6.97M (+90.39%)

What is Intellia Therapeutics, Inc. TTM cash from investing?

The current TTM cash from investing of NTLA is $352.06M

What is the all-time high TTM cash from investing for Intellia Therapeutics, Inc.?

Intellia Therapeutics, Inc. all-time high TTM cash from investing is $352.06M

What is Intellia Therapeutics, Inc. TTM cash from investing year-on-year change?

Over the past year, NTLA TTM cash from investing has changed by +$332.12M (+1665.52%)
On this page